Growth Metrics

Novartis Ag (NVS) Non-Current Debt (2017 - 2025)

Novartis Ag's Non-Current Debt history spans 9 years, with the latest figure at $27.9 billion for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 30.75% to $27.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $27.9 billion, a 30.75% increase, with the full-year FY2025 number at $27.9 billion, up 30.75% from a year prior.
  • Non-Current Debt hit $27.9 billion in Q4 2025 for Novartis Ag, up from $21.4 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for NVS hit a ceiling of $27.9 billion in Q4 2025 and a floor of $868.0 million in Q2 2021.
  • Historically, Non-Current Debt has averaged $16.8 billion across 5 years, with a median of $19.3 billion in 2022.
  • Biggest five-year swings in Non-Current Debt: crashed 96.45% in 2021 and later soared 734.68% in 2022.
  • Tracing NVS's Non-Current Debt over 5 years: stood at $22.9 billion in 2021, then dropped by 11.61% to $20.2 billion in 2022, then decreased by 8.93% to $18.4 billion in 2023, then increased by 15.89% to $21.4 billion in 2024, then surged by 30.75% to $27.9 billion in 2025.
  • Business Quant data shows Non-Current Debt for NVS at $27.9 billion in Q4 2025, $21.4 billion in Q4 2024, and $18.4 billion in Q4 2023.